GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00224076 | Stomach | GC | regulation of cell-cell adhesion | 55/1159 | 448/18723 | 9.21e-07 | 4.39e-05 | 55 |
GO:0007159 | Stomach | GC | leukocyte cell-cell adhesion | 45/1159 | 371/18723 | 1.21e-05 | 3.99e-04 | 45 |
GO:0050900 | Stomach | GC | leukocyte migration | 44/1159 | 369/18723 | 2.30e-05 | 6.81e-04 | 44 |
GO:1903037 | Stomach | GC | regulation of leukocyte cell-cell adhesion | 40/1159 | 336/18723 | 5.53e-05 | 1.30e-03 | 40 |
GO:0002685 | Stomach | GC | regulation of leukocyte migration | 28/1159 | 210/18723 | 1.04e-04 | 2.05e-03 | 28 |
GO:00059964 | Stomach | GC | monosaccharide metabolic process | 31/1159 | 257/18723 | 2.90e-04 | 4.67e-03 | 31 |
GO:00193184 | Stomach | GC | hexose metabolic process | 29/1159 | 237/18723 | 3.53e-04 | 5.54e-03 | 29 |
GO:00160525 | Stomach | GC | carbohydrate catabolic process | 21/1159 | 154/18723 | 5.38e-04 | 7.55e-03 | 21 |
GO:00442824 | Stomach | GC | small molecule catabolic process | 40/1159 | 376/18723 | 5.92e-04 | 8.09e-03 | 40 |
GO:00224071 | Stomach | CAG with IM | regulation of cell-cell adhesion | 49/1050 | 448/18723 | 6.02e-06 | 2.23e-04 | 49 |
GO:00509001 | Stomach | CAG with IM | leukocyte migration | 40/1050 | 369/18723 | 5.16e-05 | 1.32e-03 | 40 |
GO:00071591 | Stomach | CAG with IM | leukocyte cell-cell adhesion | 40/1050 | 371/18723 | 5.82e-05 | 1.44e-03 | 40 |
GO:00026851 | Stomach | CAG with IM | regulation of leukocyte migration | 26/1050 | 210/18723 | 1.27e-04 | 2.64e-03 | 26 |
GO:19030371 | Stomach | CAG with IM | regulation of leukocyte cell-cell adhesion | 36/1050 | 336/18723 | 1.52e-04 | 2.97e-03 | 36 |
GO:001605211 | Stomach | CAG with IM | carbohydrate catabolic process | 19/1050 | 154/18723 | 1.02e-03 | 1.29e-02 | 19 |
GO:000599611 | Stomach | CAG with IM | monosaccharide metabolic process | 26/1050 | 257/18723 | 2.67e-03 | 2.58e-02 | 26 |
GO:001931811 | Stomach | CAG with IM | hexose metabolic process | 24/1050 | 237/18723 | 3.77e-03 | 3.31e-02 | 24 |
GO:00224072 | Stomach | CSG | regulation of cell-cell adhesion | 48/1034 | 448/18723 | 8.67e-06 | 3.05e-04 | 48 |
GO:00509002 | Stomach | CSG | leukocyte migration | 40/1034 | 369/18723 | 3.68e-05 | 9.87e-04 | 40 |
GO:00071592 | Stomach | CSG | leukocyte cell-cell adhesion | 39/1034 | 371/18723 | 8.93e-05 | 2.07e-03 | 39 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
FUT9 | SNV | Missense_Mutation | | c.25N>A | p.Leu9Ile | p.L9I | Q9Y231 | protein_coding | tolerated(0.18) | benign(0.013) | TCGA-B5-A0JY-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | doxorubicin | SD |
FUT9 | SNV | Missense_Mutation | | c.199N>A | p.Leu67Met | p.L67M | Q9Y231 | protein_coding | deleterious(0.01) | probably_damaging(0.999) | TCGA-B5-A0JY-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | doxorubicin | SD |
FUT9 | SNV | Missense_Mutation | novel | c.656G>A | p.Gly219Glu | p.G219E | Q9Y231 | protein_coding | deleterious(0) | probably_damaging(0.986) | TCGA-B5-A1MX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Hormone Therapy | megace | SD |
FUT9 | SNV | Missense_Mutation | | c.743N>C | p.Ile248Thr | p.I248T | Q9Y231 | protein_coding | deleterious(0.03) | probably_damaging(0.989) | TCGA-B5-A3FC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
FUT9 | SNV | Missense_Mutation | | c.159N>A | p.Phe53Leu | p.F53L | Q9Y231 | protein_coding | tolerated(0.69) | benign(0.007) | TCGA-BK-A6W3-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
FUT9 | SNV | Missense_Mutation | rs199945143 | c.403N>C | p.Asn135His | p.N135H | Q9Y231 | protein_coding | tolerated(0.11) | possibly_damaging(0.649) | TCGA-BS-A0UF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
FUT9 | SNV | Missense_Mutation | novel | c.311N>G | p.His104Arg | p.H104R | Q9Y231 | protein_coding | deleterious(0.04) | possibly_damaging(0.716) | TCGA-D1-A175-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
FUT9 | SNV | Missense_Mutation | novel | c.1027N>G | p.Arg343Gly | p.R343G | Q9Y231 | protein_coding | deleterious(0.02) | probably_damaging(0.944) | TCGA-DF-A2KN-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
FUT9 | SNV | Missense_Mutation | | c.834N>T | p.Glu278Asp | p.E278D | Q9Y231 | protein_coding | deleterious(0.01) | possibly_damaging(0.85) | TCGA-E6-A1M0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | SD |
FUT9 | SNV | Missense_Mutation | | c.159N>A | p.Phe53Leu | p.F53L | Q9Y231 | protein_coding | tolerated(0.69) | benign(0.007) | TCGA-EO-A22U-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |